{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-25-000312","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2025-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.899014+00:00","generated_at":"2026-05-25T23:00:51.405417+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Renovaro enters definitive merger with AI-driven Biosymetrics for 15M shares","bullets":["Renovaro issues 15M unregistered common shares to Biosymetrics stockholders for all outstanding shares; lock-up of CEO shares for 1 year.","3M of the issued shares held in escrow for 1 year to satisfy potential indemnification claims.","Merger expected to close by March 15, 2025, subject to Biosymetrics stockholder approval and Nasdaq listing.","Biosymetrics' Elion AI platform has partnerships with Janssen, Pfizer, Merck, Supernus Pharma, and Deerfield Cures.","Combined entity to focus on AI-driven biomarker discovery and precision medicine in cancer and other diseases."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-25-000312","json":"https://secwatch.observer/filing/0001731122-25-000312.json","markdown":"https://secwatch.observer/filing/0001731122-25-000312.md","text":"https://secwatch.observer/filing/0001731122-25-000312.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000312/0001731122-25-000312-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000312/e6390_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T23:00:51.405417+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}